Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Walk and think: new app aims to speed concussion recovery in athletes

NCT ID NCT07599475

Symptom relief Sponsor: Hyunhwa Lee Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 14-day home program called BraW-Day™ that combines brain exercises (like counting backwards) with walking, delivered via a smartphone app. Researchers want to see if doing both tasks together improves thinking, balance, and mood in athletes aged 18-40 who had a concussion or mild head injury in the past 3-12 months. Participants will do daily 15-minute sessions, provide saliva samples, and complete questionnaires. The goal is to find a safe, easy way to support recovery at home.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 40 years * Self-reported history of sports-related concussion (SRC) or mild traumatic brain injury (mTBI) within the past 3 to 12 months * Meets criteria for mTBI based on a standardized screening method (e.g., Ohio State University TBI Identification Method) * Able to safely participate in light physical activity (e.g., walking) and simple cognitive tasks based on self-report and observational screening by the research team * Able to read and understand English (if applicable for study materials) * Able to provide informed consent * Has access to and is able to use a smartphone or mobile device to complete daily app-based activities Exclusion Criteria: * Age younger than 18 years or older than 40 years * History of moderate or severe traumatic brain injury * Concussion or mTBI occurring less than 3 months or more than 12 months prior to enrollment * Self-reported active medical disease or history of neurological or psychiatric conditions unrelated to concussion * Self-reported other medical conditions that would limit safe participation in light physical activity (e.g., walking or balance tasks) * Currently on prescribed medications that may significantly affect cognitive function, balance, neurological function, or safe participation in light physical activity * Inability to use a smartphone or mobile device required for study participation * Inability to read or understand English (as study materials and the mobile application are currently available only in English)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive function are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Brain Concussion oculomotor nerve paralysis traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognitive function Exosomal microrna Heart rate variability (HRV) Mild traumatic brain injury (MTBI) Oculomotor SALIVA Sports-related concussion Walking

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Nevada, Las Vegas

    Las Vegas, Nevada, 89154-3018, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.